Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1988-09

AUTHORS

M. H. Gaspard, D. Maraninchi, A. M. Stoppa, J. A. Gastaut, G. Michel, N. Tubiana, D. Blaise, G. Novakovitch, J. F. Rossi, P. J. Weiller, D. Sainty, N. Horchowski, Y. Carcassonne

ABSTRACT

Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, three, acute lymphoblastic leukemia (ALL), and two, malignant thymomas. Eleven patients (group 1) were not in complete remission (CR) at the time of BEAM, and fifteen patients (group 2) were in CR. Hematological recovery occurred in all patients. The duration of aplasia and the non-hematological toxicities were similar in both groups. Ten of the eleven patients (group 1) evaluable for response achieved CR and one achieved partial remission (PR). Five patients relapsed, and five are in continuous CR with a short follow-up (median 8 months). Among the fifteen patients in CR at the time of BEAM (group 2), four patients relapsed and ten patients are in unmaintained continuous CR with a median follow-up of 15 months (one patient died in CR). The disease-free survival is 53%, with 29% for patients receiving BEAM while in relapse (group 1) and 65% for patients receiving BEAM while in CR (group 2). These data indicate that BEAM followed by ABMT can produce a high antitumor response with an acceptable toxicity in patients with poor-risk malignancies. More... »

PAGES

256-262

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00273421

DOI

http://dx.doi.org/10.1007/bf00273421

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011436851

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3044633


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carmustine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytarabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematologic Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Lymphoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melphalan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thymoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thymus Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gaspard", 
        "givenName": "M. H.", 
        "id": "sg:person.0634547675.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634547675.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maraninchi", 
        "givenName": "D.", 
        "id": "sg:person.01364057057.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364057057.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stoppa", 
        "givenName": "A. M.", 
        "id": "sg:person.015101675464.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015101675464.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gastaut", 
        "givenName": "J. A.", 
        "id": "sg:person.07765237504.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07765237504.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pediatric Unit, CHU Timone, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.411266.6", 
          "name": [
            "Pediatric Unit, CHU Timone, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michel", 
        "givenName": "G.", 
        "id": "sg:person.013625162602.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013625162602.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tubiana", 
        "givenName": "N.", 
        "id": "sg:person.01132125053.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132125053.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blaise", 
        "givenName": "D.", 
        "id": "sg:person.0644473065.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644473065.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Blood Bank, CTS, Marseille, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Blood Bank, CTS, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Novakovitch", 
        "givenName": "G.", 
        "id": "sg:person.01155304175.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155304175.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier, Avignon, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Centre Hospitalier, Avignon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rossi", 
        "givenName": "J. F.", 
        "id": "sg:person.07403755422.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07403755422.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CHU Timone, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.411266.6", 
          "name": [
            "CHU Timone, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weiller", 
        "givenName": "P. J.", 
        "id": "sg:person.013077773464.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013077773464.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sainty", 
        "givenName": "D.", 
        "id": "sg:person.014445715014.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014445715014.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horchowski", 
        "givenName": "N.", 
        "id": "sg:person.0675073673.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675073673.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carcassonne", 
        "givenName": "Y.", 
        "id": "sg:person.0750362101.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750362101.05"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00256170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012809008", 
          "https://doi.org/10.1007/bf00256170"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00446220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042853178", 
          "https://doi.org/10.1007/bf00446220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00258119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009422749", 
          "https://doi.org/10.1007/bf00258119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1979.142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019204502", 
          "https://doi.org/10.1038/bjc.1979.142"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1988-09", 
    "datePublishedReg": "1988-09-01", 
    "description": "Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, three, acute lymphoblastic leukemia (ALL), and two, malignant thymomas. Eleven patients (group 1) were not in complete remission (CR) at the time of BEAM, and fifteen patients (group 2) were in CR. Hematological recovery occurred in all patients. The duration of aplasia and the non-hematological toxicities were similar in both groups. Ten of the eleven patients (group 1) evaluable for response achieved CR and one achieved partial remission (PR). Five patients relapsed, and five are in continuous CR with a short follow-up (median 8 months). Among the fifteen patients in CR at the time of BEAM (group 2), four patients relapsed and ten patients are in unmaintained continuous CR with a median follow-up of 15 months (one patient died in CR). The disease-free survival is 53%, with 29% for patients receiving BEAM while in relapse (group 1) and 65% for patients receiving BEAM while in CR (group 2). These data indicate that BEAM followed by ABMT can produce a high antitumor response with an acceptable toxicity in patients with poor-risk malignancies.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00273421", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "autologous bone marrow transplantation", 
      "poor-risk malignancies", 
      "complete remission", 
      "continuous complete remission", 
      "bone marrow transplantation", 
      "acute lymphoblastic leukemia", 
      "partial remission", 
      "marrow transplantation", 
      "high-dose combination chemotherapy", 
      "non-hematological toxicities", 
      "disease-free survival", 
      "duration of aplasia", 
      "higher antitumor response", 
      "intensive chemotherapy", 
      "hematological recovery", 
      "acceptable toxicity", 
      "combination chemotherapy", 
      "malignant thymoma", 
      "antitumor response", 
      "malignant lymphoma", 
      "lymphoblastic leukemia", 
      "patients", 
      "high doses", 
      "malignancy", 
      "antitumor activity", 
      "remission", 
      "chemotherapy", 
      "transplantation", 
      "melphalan", 
      "toxicity", 
      "relapse", 
      "thymoma", 
      "lymphoma", 
      "aplasia", 
      "leukemia", 
      "BCNU", 
      "doses", 
      "etoposide", 
      "response", 
      "months", 
      "survival", 
      "arabinoside", 
      "duration", 
      "group", 
      "recovery", 
      "activity", 
      "time", 
      "cytosine", 
      "data", 
      "beam", 
      "BCNU-etoposide-cytosine arabinoside", 
      "time of BEAM", 
      "unmaintained continuous CR"
    ], 
    "name": "Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies", 
    "pagination": "256-262", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011436851"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00273421"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3044633"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00273421", 
      "https://app.dimensions.ai/details/publication/pub.1011436851"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_214.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00273421"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00273421'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00273421'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00273421'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00273421'


 

This table displays all metadata directly associated to this object as RDF triples.

313 TRIPLES      22 PREDICATES      106 URIs      94 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00273421 schema:about N024eddcaeb6b4635af564f1b6d4c7982
2 N0a637274c63445b4a357c6e485a64fb1
3 N0cda2f22639e447d91baa09c5a5635da
4 N23b4044978e044e9a0cc24683cd07b6b
5 N2afdf69264d54d0a8582f6b3b14842be
6 N2d38716e7fa543c9a683d5ec97b1bdd9
7 N2de4a10822bd4857981e49832d394031
8 N42f1f8963d1049059dd6b432e5dc0b19
9 N494804f5d0934aeaae4270429a3b94c6
10 N52901ffa6034430d94901c32630ac905
11 N558836c4d0924cc0bf80ec42478113ce
12 N698d87d4e3c44212a7c32c7aaf451706
13 N6ce65239d11d4c4a839e765ac6c3b021
14 N71a3d15e613441daa017aa2443ef5e51
15 N77f3ac9f49834a298052b9da56842bcd
16 N96423e59c8f644fdb3d111b115c3393f
17 N9aeaea14ba9d467a95578ebfb25af488
18 Nd07b9ef0e74942cfae34903e7bee4470
19 Nd5b0e6f6b7c34e71b6c12131a8c75b3b
20 Ne5d26791feef45389aa36948ab6e251b
21 Nf9b86a27009346218b98cc5676040222
22 Nfe15d64a526346c6b72482e3c37d6446
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author Nd807053a93f249b7b16b78568446219d
26 schema:citation sg:pub.10.1007/bf00256170
27 sg:pub.10.1007/bf00258119
28 sg:pub.10.1007/bf00446220
29 sg:pub.10.1038/bjc.1979.142
30 schema:datePublished 1988-09
31 schema:datePublishedReg 1988-09-01
32 schema:description Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, three, acute lymphoblastic leukemia (ALL), and two, malignant thymomas. Eleven patients (group 1) were not in complete remission (CR) at the time of BEAM, and fifteen patients (group 2) were in CR. Hematological recovery occurred in all patients. The duration of aplasia and the non-hematological toxicities were similar in both groups. Ten of the eleven patients (group 1) evaluable for response achieved CR and one achieved partial remission (PR). Five patients relapsed, and five are in continuous CR with a short follow-up (median 8 months). Among the fifteen patients in CR at the time of BEAM (group 2), four patients relapsed and ten patients are in unmaintained continuous CR with a median follow-up of 15 months (one patient died in CR). The disease-free survival is 53%, with 29% for patients receiving BEAM while in relapse (group 1) and 65% for patients receiving BEAM while in CR (group 2). These data indicate that BEAM followed by ABMT can produce a high antitumor response with an acceptable toxicity in patients with poor-risk malignancies.
33 schema:genre article
34 schema:inLanguage en
35 schema:isAccessibleForFree false
36 schema:isPartOf N2e9ce7c7ea4b44f2b641325d103685a6
37 N410b922930834be988c410a56a1c54e9
38 sg:journal.1088364
39 schema:keywords BCNU
40 BCNU-etoposide-cytosine arabinoside
41 acceptable toxicity
42 activity
43 acute lymphoblastic leukemia
44 antitumor activity
45 antitumor response
46 aplasia
47 arabinoside
48 autologous bone marrow transplantation
49 beam
50 bone marrow transplantation
51 chemotherapy
52 combination chemotherapy
53 complete remission
54 continuous complete remission
55 cytosine
56 data
57 disease-free survival
58 doses
59 duration
60 duration of aplasia
61 etoposide
62 group
63 hematological recovery
64 high doses
65 high-dose combination chemotherapy
66 higher antitumor response
67 intensive chemotherapy
68 leukemia
69 lymphoblastic leukemia
70 lymphoma
71 malignancy
72 malignant lymphoma
73 malignant thymoma
74 marrow transplantation
75 melphalan
76 months
77 non-hematological toxicities
78 partial remission
79 patients
80 poor-risk malignancies
81 recovery
82 relapse
83 remission
84 response
85 survival
86 thymoma
87 time
88 time of BEAM
89 toxicity
90 transplantation
91 unmaintained continuous CR
92 schema:name Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies
93 schema:pagination 256-262
94 schema:productId N712cb3e99a3746f69085e937ddb56e72
95 Nd86ab44e246f4f64a59aecb8ea1a2040
96 Ne17f0430e8f14b28b32f4dfe1b72832f
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011436851
98 https://doi.org/10.1007/bf00273421
99 schema:sdDatePublished 2021-12-01T19:06
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher Nd42808f5922240e2b728bb9b193568f9
102 schema:url https://doi.org/10.1007/bf00273421
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N024eddcaeb6b4635af564f1b6d4c7982 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 N0a637274c63445b4a357c6e485a64fb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Leukemia, Lymphoid
111 rdf:type schema:DefinedTerm
112 N0cda2f22639e447d91baa09c5a5635da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Remission Induction
114 rdf:type schema:DefinedTerm
115 N18b69ab83fd845fca2a45bbd1b0713e1 rdf:first sg:person.014445715014.01
116 rdf:rest Ne0cef50810e3494cba707d6ae16ddca2
117 N23b4044978e044e9a0cc24683cd07b6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Recurrence
119 rdf:type schema:DefinedTerm
120 N2afdf69264d54d0a8582f6b3b14842be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Melphalan
122 rdf:type schema:DefinedTerm
123 N2d38716e7fa543c9a683d5ec97b1bdd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Lymphoma
125 rdf:type schema:DefinedTerm
126 N2de4a10822bd4857981e49832d394031 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Middle Aged
128 rdf:type schema:DefinedTerm
129 N2e9ce7c7ea4b44f2b641325d103685a6 schema:issueNumber 3
130 rdf:type schema:PublicationIssue
131 N2f8036e5704c4532a44b76d88d3071d9 rdf:first sg:person.0750362101.05
132 rdf:rest rdf:nil
133 N31b5c6414f9c434c991be8fb291ac4c6 rdf:first sg:person.01132125053.01
134 rdf:rest N874d164d1b5547b9b997a618984a2870
135 N410b922930834be988c410a56a1c54e9 schema:volumeNumber 22
136 rdf:type schema:PublicationVolume
137 N42f1f8963d1049059dd6b432e5dc0b19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Thymoma
139 rdf:type schema:DefinedTerm
140 N494804f5d0934aeaae4270429a3b94c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Adult
142 rdf:type schema:DefinedTerm
143 N52901ffa6034430d94901c32630ac905 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Cytarabine
145 rdf:type schema:DefinedTerm
146 N5456f171120c45a6b4c843b7d4e875f2 rdf:first sg:person.07765237504.22
147 rdf:rest N906381d99d7f4c8c83be213556a621fb
148 N558836c4d0924cc0bf80ec42478113ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Antineoplastic Combined Chemotherapy Protocols
150 rdf:type schema:DefinedTerm
151 N6346f6bf74c64a1389715a1de5c514ba rdf:first sg:person.015101675464.51
152 rdf:rest N5456f171120c45a6b4c843b7d4e875f2
153 N698d87d4e3c44212a7c32c7aaf451706 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Combined Modality Therapy
155 rdf:type schema:DefinedTerm
156 N6ce65239d11d4c4a839e765ac6c3b021 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Carmustine
158 rdf:type schema:DefinedTerm
159 N712cb3e99a3746f69085e937ddb56e72 schema:name dimensions_id
160 schema:value pub.1011436851
161 rdf:type schema:PropertyValue
162 N71a3d15e613441daa017aa2443ef5e51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Child, Preschool
164 rdf:type schema:DefinedTerm
165 N77f3ac9f49834a298052b9da56842bcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Adolescent
167 rdf:type schema:DefinedTerm
168 N7f64d7737e7043b7b1bec0cc42855e22 rdf:first sg:person.07403755422.39
169 rdf:rest Ne2d0c70bf50642d39701715deabc79d2
170 N874d164d1b5547b9b997a618984a2870 rdf:first sg:person.0644473065.59
171 rdf:rest Ndecc96fa11584e1ebf7578c4f969d943
172 N906381d99d7f4c8c83be213556a621fb rdf:first sg:person.013625162602.73
173 rdf:rest N31b5c6414f9c434c991be8fb291ac4c6
174 N96423e59c8f644fdb3d111b115c3393f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Male
176 rdf:type schema:DefinedTerm
177 N9aeaea14ba9d467a95578ebfb25af488 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Hematologic Diseases
179 rdf:type schema:DefinedTerm
180 Nd07b9ef0e74942cfae34903e7bee4470 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Etoposide
182 rdf:type schema:DefinedTerm
183 Nd42808f5922240e2b728bb9b193568f9 schema:name Springer Nature - SN SciGraph project
184 rdf:type schema:Organization
185 Nd5b0e6f6b7c34e71b6c12131a8c75b3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Bone Marrow Transplantation
187 rdf:type schema:DefinedTerm
188 Nd807053a93f249b7b16b78568446219d rdf:first sg:person.0634547675.86
189 rdf:rest Nff620e4d19eb4319b7c2008509915e6b
190 Nd86ab44e246f4f64a59aecb8ea1a2040 schema:name pubmed_id
191 schema:value 3044633
192 rdf:type schema:PropertyValue
193 Ndecc96fa11584e1ebf7578c4f969d943 rdf:first sg:person.01155304175.19
194 rdf:rest N7f64d7737e7043b7b1bec0cc42855e22
195 Ne0cef50810e3494cba707d6ae16ddca2 rdf:first sg:person.0675073673.71
196 rdf:rest N2f8036e5704c4532a44b76d88d3071d9
197 Ne17f0430e8f14b28b32f4dfe1b72832f schema:name doi
198 schema:value 10.1007/bf00273421
199 rdf:type schema:PropertyValue
200 Ne2d0c70bf50642d39701715deabc79d2 rdf:first sg:person.013077773464.57
201 rdf:rest N18b69ab83fd845fca2a45bbd1b0713e1
202 Ne5d26791feef45389aa36948ab6e251b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Child
204 rdf:type schema:DefinedTerm
205 Nf9b86a27009346218b98cc5676040222 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Thymus Neoplasms
207 rdf:type schema:DefinedTerm
208 Nfe15d64a526346c6b72482e3c37d6446 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Female
210 rdf:type schema:DefinedTerm
211 Nff620e4d19eb4319b7c2008509915e6b rdf:first sg:person.01364057057.31
212 rdf:rest N6346f6bf74c64a1389715a1de5c514ba
213 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
214 schema:name Medical and Health Sciences
215 rdf:type schema:DefinedTerm
216 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
217 schema:name Oncology and Carcinogenesis
218 rdf:type schema:DefinedTerm
219 sg:journal.1088364 schema:issn 0344-5704
220 1432-0843
221 schema:name Cancer Chemotherapy and Pharmacology
222 schema:publisher Springer Nature
223 rdf:type schema:Periodical
224 sg:person.01132125053.01 schema:affiliation grid-institutes:grid.418443.e
225 schema:familyName Tubiana
226 schema:givenName N.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132125053.01
228 rdf:type schema:Person
229 sg:person.01155304175.19 schema:affiliation grid-institutes:None
230 schema:familyName Novakovitch
231 schema:givenName G.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155304175.19
233 rdf:type schema:Person
234 sg:person.013077773464.57 schema:affiliation grid-institutes:grid.411266.6
235 schema:familyName Weiller
236 schema:givenName P. J.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013077773464.57
238 rdf:type schema:Person
239 sg:person.013625162602.73 schema:affiliation grid-institutes:grid.411266.6
240 schema:familyName Michel
241 schema:givenName G.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013625162602.73
243 rdf:type schema:Person
244 sg:person.01364057057.31 schema:affiliation grid-institutes:grid.418443.e
245 schema:familyName Maraninchi
246 schema:givenName D.
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364057057.31
248 rdf:type schema:Person
249 sg:person.014445715014.01 schema:affiliation grid-institutes:grid.418443.e
250 schema:familyName Sainty
251 schema:givenName D.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014445715014.01
253 rdf:type schema:Person
254 sg:person.015101675464.51 schema:affiliation grid-institutes:grid.418443.e
255 schema:familyName Stoppa
256 schema:givenName A. M.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015101675464.51
258 rdf:type schema:Person
259 sg:person.0634547675.86 schema:affiliation grid-institutes:grid.418443.e
260 schema:familyName Gaspard
261 schema:givenName M. H.
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634547675.86
263 rdf:type schema:Person
264 sg:person.0644473065.59 schema:affiliation grid-institutes:grid.418443.e
265 schema:familyName Blaise
266 schema:givenName D.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644473065.59
268 rdf:type schema:Person
269 sg:person.0675073673.71 schema:affiliation grid-institutes:grid.418443.e
270 schema:familyName Horchowski
271 schema:givenName N.
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675073673.71
273 rdf:type schema:Person
274 sg:person.07403755422.39 schema:affiliation grid-institutes:None
275 schema:familyName Rossi
276 schema:givenName J. F.
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07403755422.39
278 rdf:type schema:Person
279 sg:person.0750362101.05 schema:affiliation grid-institutes:grid.418443.e
280 schema:familyName Carcassonne
281 schema:givenName Y.
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750362101.05
283 rdf:type schema:Person
284 sg:person.07765237504.22 schema:affiliation grid-institutes:grid.418443.e
285 schema:familyName Gastaut
286 schema:givenName J. A.
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07765237504.22
288 rdf:type schema:Person
289 sg:pub.10.1007/bf00256170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012809008
290 https://doi.org/10.1007/bf00256170
291 rdf:type schema:CreativeWork
292 sg:pub.10.1007/bf00258119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009422749
293 https://doi.org/10.1007/bf00258119
294 rdf:type schema:CreativeWork
295 sg:pub.10.1007/bf00446220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042853178
296 https://doi.org/10.1007/bf00446220
297 rdf:type schema:CreativeWork
298 sg:pub.10.1038/bjc.1979.142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019204502
299 https://doi.org/10.1038/bjc.1979.142
300 rdf:type schema:CreativeWork
301 grid-institutes:None schema:alternateName Blood Bank, CTS, Marseille, France
302 Centre Hospitalier, Avignon, France
303 schema:name Blood Bank, CTS, Marseille, France
304 Centre Hospitalier, Avignon, France
305 rdf:type schema:Organization
306 grid-institutes:grid.411266.6 schema:alternateName CHU Timone, Marseille, France
307 Pediatric Unit, CHU Timone, Marseille, France
308 schema:name CHU Timone, Marseille, France
309 Pediatric Unit, CHU Timone, Marseille, France
310 rdf:type schema:Organization
311 grid-institutes:grid.418443.e schema:alternateName Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France
312 schema:name Marrow Transplant Unit. Clinique des Maladies du Sang, Inserm U119-Institut Paoli-Calmettes, Marseille, France
313 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...